» Articles » PMID: 30654222

Piperazine-azole-fluoroquinolone Hybrids: Conventional and Microwave Irradiated Synthesis, Biological Activity Screening and Molecular Docking Studies

Overview
Journal Bioorg Chem
Publisher Elsevier
Specialties Biochemistry
Chemistry
Date 2019 Jan 18
PMID 30654222
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A series of new 1,2,4-triazole and 1,3,4-oxadiazole derivatives was obtained via several steps sequential reactions of phenyl piperazine. Then, these compounds were converted to the corresponding fluoroquinolone hybrids via one pot three component Mannich reaction. All the reactions were examined under conventional and microwave mediated conditions, and optimum conditions were determined. The effect of different solvents and microwave power on microwave prompted reactions was investigated as well. All the newly synthesized compounds were characterized by FTIR, H NMR, C NMR and EI MS spectral techniques. The antimicrobial activity, DNA gyrase and Topoisomerase IV inhibition potentials were performed. The results obtained showed that fluoroquinolone hybrids possess good antimicrobial activity. Moreover, Fluoroquinolone-azole-piperazine hybrids synthesized in the present study displayed excellent DNA gyrase inhibition. To unveil the interaction mode of compounds to receptor, a molecular docking study was performed. With an average least binding energy of -9.5 kcal/mol, all compounds were found to have remarkable inhibitory potentials against DNA gyrase (E. coli).

Citing Articles

mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells.

Bulbul M, Mermer A, Kolbasi B, Kocabas F, Kalender S, Kirectepe Aydin K Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770404 PMC: 11678851. DOI: 10.3390/ph17121562.


Synthesis of ciprofloxacin-linked 1,2,3-triazole conjugates as potent antibacterial agents using click chemistry: exploring their function as DNA gyrase inhibitors - and -based studies.

Patel U, Tiwari P, Tilak R, Joshi G, Kumar R, Agarwal A RSC Adv. 2024; 14(24):17051-17070.

PMID: 38818013 PMC: 11138863. DOI: 10.1039/d4ra01332h.


-Heterocycles as Promising Antiviral Agents: A Comprehensive Overview.

Ahmad G, Sohail M, Bilal M, Rasool N, Qamar M, Ciurea C Molecules. 2024; 29(10).

PMID: 38792094 PMC: 11123935. DOI: 10.3390/molecules29102232.


Recent Development of DNA Gyrase Inhibitors: An Update.

Piplani P, Kumar A, Kulshreshtha A, Vohra T, Piplani V Mini Rev Med Chem. 2023; 24(10):1001-1030.

PMID: 37909434 DOI: 10.2174/0113895575264264230921080718.


Hybrid Azine Derivatives: A Useful Approach for Antimicrobial Therapy.

Amariucai-Mantu D, Mangalagiu V, Bejan I, Aricu A, Mangalagiu I Pharmaceutics. 2022; 14(10).

PMID: 36297461 PMC: 9610418. DOI: 10.3390/pharmaceutics14102026.